Skip to main content

Pregnancy and Lactation in Patients with MS

This session presents the most recent findings and updates for the treatment of pregnant or lactating MS patients. By Bassem Yamout.

9th December 2021, Pre-MENACTRIMS symposium, as a warm-up for the Sixth MENACTRIMS Congress, ParadigMS Foundation organised this enriching Pre-MENACTRIMS Symposium. Here you can review the full keynote on pregnancy and Lactation in Patients with MS.


This session presents the most recent findings and updates for the treatment of pregnant or lactating MS patients. This includes family planning; the effect of pregnancy on the disease course, including relapses; post-partum disease activity; treatment during pregnancy and breastfeeding and the compatibility of disease modifying therapies and breastfeeding. The conclusions illustrate how to support patients making informed decisions on the basis of the presented information.

Professor of Clinical Neurology. Director, Neurology Institute
American University of Beirut, Harley Street Medical Center Abu Dhabi

Bassem Yamout is currently a Professor of Clinical Neurology at the American University of Beirut Medical Center and the Director of the Neurology Institute at Harley Street Medical Center. He is also the Head of the MS Center of the same institute in Abu Dhabi.

Prof. Yamout graduated from medical school at the American University of Beirut in 1984, received his training in neurology at the University of Cincinnati-Ohio followed by a fellowship at the Montreal Neurological Institute-McGill University. In 1988, he joined the Faculty of the American University of Beirut.

His main focus of research is in the field of multiple sclerosis. He is currently the President of the MENACTRIMS, Head of Clinical Research at the Multiple Sclerosis Center, a Fellow of the American Academy of Neurology, and a member of multiple regional and international MS advisory boards.

Prof. Yamout is one of the leading experts on multiple sclerosis in the Middle East and Arab region with recent research on epidemiology of the disease in the region, quality of life of patients in the Middle East, novel therapies such as stem cell transplantation and venous stenosis, and the impact of wars on the course of multiple sclerosis. In addition, he is currently the principal investigator on several ongoing international multiple sclerosis research trials.
He has authored many research and review papers and is currently the Chief Editor of the MS newsletter “MS Today”, and on the editorial board of “Multiple Sclerosis and Related Disorders.”



  • Directors

  • Author(s)

    Prof Bassem Yamout
  • Country

    Abu Dhabi
  • Release Date

    December 09, 2021
  • Views


Do subscriptions auto-renew?
Your subscription will automatically renew on a monthly or yearly basis, depending on the plan you have chosen. If you cancel your plan, it will not renew at the end of your subscription cycle. It will end once the period you have paid for is over.
What happens if I subscribe as a healthcare practitioner if I am not a healthcare practitioner?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, you will be banned immediately from the community and could be liable to prosecution.
How can I cancel my trial or subscription?
You can cancel your trial or subscription in your account settings. If you cancel during the trial period you will not be charged.